CRNXCrinetics Pharmaceuticals, Inc.

$34.99

What is the market doing?

What the tape says about CRNX

Crinetics Pharmaceuticals, Inc. is +13% over the past year while the S&P 500 is +23%: 9.5 points behind the market.

+13%

1-year return · S&P 500 +23%

vs 200-day average
+74%

vs 200-day average · a clear uptrend

RSI (14)
91

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
0.00%

Below its 52-week high

2024-08-06$25.56 – $84.85 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$34.99
1 monthS&P 500 +3.7%
−4.9%
1 yearS&P 500 +23%
+13%
5 yearsS&P 500 +87%
+81%
vs 50-day average$65.35
+30%
52-week high
$84.85
52-week low
$26.85
Annualised volatility
112%
Calendar-year price return
YearReturn
2026 (year to date)+82%
2025−9.0%
2024+44%
2023+94%
2022−36%
2021+101%
2020−44%
2019−16%
Average return by calendar month, 2018–2026
MonthYearsPositiveAverage
Jan84 of 8−7.8%
Feb84 of 8−2.2%
Mar82 of 8−5.7%
Apr85 of 8+6.9%
May84 of 8−2.6%
Jun84 of 8−0.35%
Jul84 of 8+15%
Aug95 of 9+5.1%
Sep83 of 8+10%
Oct84 of 8+0.75%
Nov87 of 8+10%
Dec86 of 8+3.7%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.